New legislation for Medicare Part B beneficiaries has recently been reintroduced to the Senate to give underserved communities access to pharmacist-provided care. Read More »
New data released by the Department of Health and Human Services shows that adults with disabilities on Medicare continue to save on prescriptions, and that there has been an increase in benefits from last year as a result of the Affordable Care Act. Read More »
The Centers for Medicare and Medicaid Services hit a snag last week in seeking approval of a proposal that requires hospitals to have antimicrobial stewardship programs participating in Medicare and Medicaid programs. Read More »
The Centers for Disease Control and Prevention have released new resources to encourage pharmacists to take a more active role in the management of hypertension among their patients. Read More »
The Centers for Disease Control and Prevention (CDC) recently announced 10 critical contributions toward the fight against the Zika virus in 2016. Read More »
Marrk Merritt, president and CEO of the Pharmaceutical Care Management Association, writes, "The truth is PBMs reduce costs for payers and consumers by 30 percent or more and are part of the solution. It’s time for drug manufacturers to take responsibility for their own business mistakes instead of blaming others." Read More »
The Centers for Disease Control and Prevention has awarded $184 million in funding to various groups in an effort to protect Americans from Zika virus infection. Read More »
The American Journal of Health-System Pharmacy has applauded the 21st Century Cures Act was signed into law by President Barack Obama on Dec. 13. Read More »
Teva Pharmaceuticals Industries Ltd. (Teva) recently announced a settlement with the United States government related to allegations of violating the Foreign Corrupt Practices Act (FCPA) in Ukraine, Mexico and Russia. Read More »
The Oncologic Drugs Advisory Committee, which is part of the U.S. Food and Drug Administration, has voted that Spectrum Pharmaceuticals' Qapzola has not displayed considerable indication of a more effective treatment compared to placebo for immediate intravesical instillation post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer. Read More »
The National Association of Chain Drug Stores RxIMPACT Votes, a leader in the pharmaceutical industry in motivating voters with outstanding, nonpartisan get-out-the-vote initiatives, is focused on raising voter registration and the interest of politics during their campaigns. Read More »
Teva Pharmaceuticals Industries' negotiations regarding the violation of the Foreign Corrupt Practices Act have concluded with a resolution of investigations in Ukraine, Mexico and Russia, where the subsidiary pleaded guilty. Read More »
The National Association of Chain Drug Stores, the National Community Pharmacists Association, the American Pharmacists Association and the National Alliance of State Pharmacy Associations have collaborated to send a letter to the incoming Donald Trump administration in that outlines necessary steps that will leverage pharmacy patient care and cut costs resulting from untreated conditions. Read More »
A new report by the Surgeon General has discovered that alcohol and drug misuse and severe substance addiction is one of the nation’s crucial health concerns. Read More »
Prime Therapeutics has released a guide on how to enroll in health insurance to avoid tax penalties. Read More »
The American Pharmacists Association recently hosted 650 pharmacists at its 2016 Joint Federal Pharmacy Seminar in Oxon Hill, Maryland. Read More »
In the dance between drug and insurance companies over the cost of medicines and which ones should be prescribed, step therapy or “fail first” policies are increasingly popular. Read More »
Vertex Pharmaceuticals has released an update on the development of its upcoming Phase 3 program involving its investigational compound VX-661. Read More »
Tyr Pharma's Resolaris has been granted Fast Track designation by the Food and Drug Administration. Read More »
Astellas Pharma and Pfizer's joint-supplemental New Drug Application that will see the update of the XTANDI capsules product label has been approved by the Food and Drug Administration. Read More »
Alerts Sign-up
